Alnylam Pharmaceuticals, Inc. (ALNY): Price and Financial Metrics
Alnylam Pharmaceuticals, Inc. (ALNY)
Today's Latest Price: $91.44 USD
2.28 (2.56%)
Updated Oct 23 11:48am
Add ALNY to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
ALNY Stock Summary
- Alnylam Pharmaceuticals Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than just 10.22% of US listed stocks.
- ALNY's price/sales ratio is 89.83; that's higher than the P/S ratio of 97.91% of US stocks.
- With a year-over-year growth in debt of 1,021.86%, Alnylam Pharmaceuticals Inc's debt growth rate surpasses 97.55% of about US stocks.
- Stocks that are quantitatively similar to ALNY, based on their financial statements, market capitalization, and price volatility, are RESN, HRTX, BCDA, ATOM, and EDIT.
- Visit ALNY's SEC page to see the company's official filings. To visit the company's web site, go to www.alnylam.com.
ALNY Daily Price Range
ALNY 52-Week Price Range
ALNY Stock Price Chart More Charts
ALNY Price/Volume Stats
| Current price | $91.44 |
| Prev. close | $89.16 |
| Day low | $88.81 |
| Day high | $91.49 |
| 50-day MA | $81.89 |
| 200-day MA | $79.88 |
| 52-week high | $96.08 |
| 52-week low | $60.27 |
| Volume | 153,140 |
| Avg. volume | 814,422 |
| Dividend yield | N/A |
| Market Cap | 10.17B |
Alnylam Pharmaceuticals, Inc. (ALNY) Company Bio
Alnylam Pharmaceuticals is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi. The company was founded in 2002 and is based in Cambridge, Massachusetts.
Top Stories View All
Best & Worst Performing Stock Industries for October 22, 2019
Best & Worst Performing Small Cap Stocks for October 22, 2019
Best & Worst Performing Mid Cap Stocks for October 22, 2019
Best & Worst Performing Large Cap Stocks for October 22, 2019
Best & Worst Performing Mega Cap Stocks for October 22, 2019
View All Top Stories
Loading social stream, please wait...